This is the best-selling product from the portfolio of Sanofi by volume, also leading in the ranking of the best-selling drugs in Romania (also by volume), according to Sanofi representatives, quoting data from IMS Health market research company.
Algocalmin is a drug released on the basis of a medical prescription and has been the best-selling drug for several years.
“16% of Sanofi’s volume sales are generated by Algocalmin,” said Simona Cocos, general manager of Zentiva Romania. She quotes IMS Health data referring to Sanofi group (not including Pasteur) on the domestic market.
Algocalmin is manufactured by Zentiva plant of Bucharest, which is owned by French Sanofi. The drug was launched in the early ‘60s.
The Bucharest plant is part of Sanofi’s export network, which expects deliveries abroad to come to account for 30% in the volume of production this year, double against 2013. According to previous information, Sanofi exports 24 products on 15 markets and the number of states drugs manufactured in Romania reach should double.
Sanofi-Aventis Romania SRL in 2013 posted revenue of 839.8 million lei (EUR190 million) and net profit of RON11.8 million (EUR2.7 million), according to Trade Registry data. In 2012, the company has reported revenue of RON952 million (EUR213 million) and profit of RON42.2 million (EUR9.6 million).
(English version by Catalina Apostoiu)